AbbVie and Scripps Research plan to develop anti-viral for Covid-19
The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
This predictive technology empowers people with diabetes to take preventive action before complications arise
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Subscribe To Our Newsletter & Stay Updated